PERRIGO Co plc
For the period ended Sep 26, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 26, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Subsequent Events
NOTE 18 -SUBSEQUENT EVENTS
On October 29, 2026, we entered into a definitive agreement pursuant to which MeridianMade will acquire our Infant Formula business for total consideration of up to $175 million. The transaction consideration consists of $40 million in cash at closing and up to an additional $135 million contingent on the achievement of future performance milestones through 2030.
The criteria for reporting our Infant Formula business as held for sale were met after the balance sheet date, and therefore we classified the business as held and used as of September 26, 2026. After considering expected carrying value relative to cash proceeds and an estimate of fair value of the contingent milestones, we expect to recognize a loss between $275.0 million and $375.0 million resulting from the measurement as held for sale during the fourth quarter of 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.